§ 13F · FUND PROFILE
Vivo Capital, LLC.
AUM · $1.1B (13F)Positions · 47Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$59M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 14, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | TRVI | Trevi Therapeutics Inc | 5.09M | $95M | 8.7% | −67% |
| 2 | PRAX | Praxis Precision Medicines | 271K | $91M | 8.3% | −73% |
| 3 | ERAS | Erasca Inc | 4.13M | $76M | 6.9% | −89% |
| 4 | AVBP | Arrivent BioPharma Inc | 1.68M | $58M | 5.3% | −37% |
| 5 | ABVX | Abivax SA - ADR | 415K | $55M | 5.0% | −42% |
| 6 | TNGX | Tango Therapeutics Inc | 1.38M | $43M | 3.9% | −79% |
| 7 | CRVS | Corvus Pharmaceuticals Inc | 2.81M | $42M | 3.8% | −67% |
| 8 | DRUG | Bright Minds Biosciences Inc | 557K | $39M | 3.6% | −67% |
| 9 | SVA | Sinovac Biotech Ltd. | 5.90M | $38M | 3.5% | −67% |
| 10 | TENX | Tenax Therapeutics Inc | 2.50M | $36M | 3.3% | +300% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE VIVO SIGNAL
AC read
Vivo Capital, LLC is a Other fund managing $1.1 billion in assets. The fund runs a portfolio of 47 positions.
Read the full dossier →